• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非酒精性脂肪性肝病进展相关危险因素的分析与研究:一项回顾性队列研究。

Analysis and study of risk factors related to the progression of non-alcoholic fatty liver disease: A retrospective cohort study.

作者信息

Yang JunRan, Zhou Zhenhua

机构信息

Shuguang Hospital Affiliated to Shanghai University of Chinese Traditional Medicine, Shanghai, China.

出版信息

PLoS One. 2025 May 7;20(5):e0322990. doi: 10.1371/journal.pone.0322990. eCollection 2025.

DOI:10.1371/journal.pone.0322990
PMID:40333922
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12057958/
Abstract

OBJECTIVE

Non-alcoholic fatty liver disease (NAFLD) is becoming increasingly prevalent worldwide. This study aimed to analyze the risk factors associated with NAFLD progression by collecting and evaluating clinical data of NAFLD patients, providing a scientific basis for its prevention and treatment.

METHODS

Clinical data of NAFLD patients from June 2015 to June 2016 were retrospectively collected, including gender, age, alanine aminotransferase (ALT), aspartate aminotransferase(AST), alkaline phosphatase(ALP),γ-glutamyltranspeptidase (GGT), triglycerides (TG), total cholesterol (TC), high-density lipoprotein (HDL), low-density lipoprotein (LDL), fasting blood glucose (FBG), and visceral fat area (VFA). All patients were stratified by gender and age, and logistic regression analysis was used to explore the risk factors for NAFLD disease progression.

RESULTS

ALT, TG, FBG, and VFA were identified as independent risk factors for NAFLD progression. Stratified analysis showed that in male patients, ALT, TG, and VFA were independent risk factors, whereas in female patients, TG, FBG, and VFA were identified as independent risk factors. Age-stratified analysis revealed that ALT, TG, and VFA were significant risk factors for progression in young and middle-aged patients. At the same time, age, ALT, TG, and FBG were substantial in elderly patients.

CONCLUSION

Different risk factors should be closely monitored in sex- and age-specific populations to prevent NAFLD progression effectively.

摘要

目的

非酒精性脂肪性肝病(NAFLD)在全球范围内日益普遍。本研究旨在通过收集和评估NAFLD患者的临床数据,分析与NAFLD进展相关的危险因素,为其预防和治疗提供科学依据。

方法

回顾性收集2015年6月至2016年6月NAFLD患者的临床数据,包括性别、年龄、丙氨酸氨基转移酶(ALT)、天冬氨酸氨基转移酶(AST)、碱性磷酸酶(ALP)、γ-谷氨酰转肽酶(GGT)、甘油三酯(TG)、总胆固醇(TC)、高密度脂蛋白(HDL)、低密度脂蛋白(LDL)、空腹血糖(FBG)和内脏脂肪面积(VFA)。所有患者按性别和年龄分层,采用逻辑回归分析探讨NAFLD疾病进展的危险因素。

结果

ALT、TG、FBG和VFA被确定为NAFLD进展的独立危险因素。分层分析显示,在男性患者中,ALT、TG和VFA是独立危险因素,而在女性患者中,TG、FBG和VFA被确定为独立危险因素。年龄分层分析显示,ALT、TG和VFA是中青年患者进展的显著危险因素。同时,年龄、ALT、TG和FBG在老年患者中也很重要。

结论

应在特定性别和年龄人群中密切监测不同的危险因素,以有效预防NAFLD进展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f629/12057958/152cba9f1215/pone.0322990.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f629/12057958/7d51278f7f02/pone.0322990.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f629/12057958/152cba9f1215/pone.0322990.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f629/12057958/7d51278f7f02/pone.0322990.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f629/12057958/152cba9f1215/pone.0322990.g002.jpg

相似文献

1
Analysis and study of risk factors related to the progression of non-alcoholic fatty liver disease: A retrospective cohort study.非酒精性脂肪性肝病进展相关危险因素的分析与研究:一项回顾性队列研究。
PLoS One. 2025 May 7;20(5):e0322990. doi: 10.1371/journal.pone.0322990. eCollection 2025.
2
Prevalence and associated metabolic factors of fatty liver disease in the elderly.老年人脂肪肝的患病率及相关代谢因素。
Exp Gerontol. 2013 Aug;48(8):705-9. doi: 10.1016/j.exger.2013.05.059. Epub 2013 May 27.
3
Non-alcoholic fatty liver disease is closely associated with sub-clinical inflammation: a case-control study on Asian Indians in North India.非酒精性脂肪性肝病与亚临床炎症密切相关:一项针对印度北部亚裔人群的病例对照研究。
PLoS One. 2013;8(1):e49286. doi: 10.1371/journal.pone.0049286. Epub 2013 Jan 11.
4
Clinical model to predict the risk of nonalcoholic fatty liver disease: A secondary analysis of data from a cross-sectional study.临床模型预测非酒精性脂肪性肝病风险:一项横断面研究数据的二次分析。
Medicine (Baltimore). 2024 Sep 6;103(36):e39437. doi: 10.1097/MD.0000000000039437.
5
A vegetarian diet does not protect against nonalcoholic fatty liver disease (NAFLD): A cross-sectional study between Buddhist priests and the general population.素食不能预防非酒精性脂肪性肝病(NAFLD):佛教僧侣与普通人群的横断面研究
Turk J Gastroenterol. 2015 Jul;26(4):336-43. doi: 10.5152/tjg.2015.0046. Epub 2015 Jun 2.
6
The effect of chitosan supplementation on liver function, hepatic steatosis predictors, and metabolic indicators in adults with non-alcoholic fatty liver disease: a randomized, double-blinded, placebo-controlled, clinical trial.壳聚糖补充剂对非酒精性脂肪性肝病成人患者肝功能、肝脂肪变性预测指标及代谢指标的影响:一项随机、双盲、安慰剂对照临床试验。
J Health Popul Nutr. 2025 Mar 1;44(1):60. doi: 10.1186/s41043-025-00797-3.
7
Risk factor compositions of nonalcoholic fatty liver disease change with body mass index in males and females.非酒精性脂肪性肝病的危险因素构成在男性和女性中随体重指数而变化。
Oncotarget. 2016 Jun 14;7(24):35632-35642. doi: 10.18632/oncotarget.9691.
8
Association between the alanine aminotransferase/aspartate aminotransferase ratio and new-onset non-alcoholic fatty liver disease in a nonobese Chinese population: a population-based longitudinal study.非肥胖中国人群中丙氨酸氨基转移酶/天冬氨酸氨基转移酶比值与新发非酒精性脂肪性肝病的关系:一项基于人群的纵向研究。
Lipids Health Dis. 2020 Nov 25;19(1):245. doi: 10.1186/s12944-020-01419-z.
9
The newly proposed alanine aminotransferase to high-density lipoprotein cholesterol ratio has shown effectiveness in identifying non-alcoholic fatty liver disease.新提出的丙氨酸氨基转移酶与高密度脂蛋白胆固醇比值在识别非酒精性脂肪性肝病方面显示出有效性。
Front Endocrinol (Lausanne). 2023 Aug 31;14:1239398. doi: 10.3389/fendo.2023.1239398. eCollection 2023.
10
The Chinese medicine Chai Hu Li Zhong Tang protects against non-alcoholic fatty liver disease by activating AMPKα.中药柴胡理中汤通过激活 AMPKα 来预防非酒精性脂肪肝疾病。
Biosci Rep. 2018 Nov 7;38(6). doi: 10.1042/BSR20180644. Print 2018 Dec 21.

本文引用的文献

1
The metabolic profiles and body composition of non-obese metabolic associated fatty liver disease.非肥胖型代谢相关脂肪性肝病的代谢谱和身体组成
Front Endocrinol (Lausanne). 2024 Feb 5;15:1322563. doi: 10.3389/fendo.2024.1322563. eCollection 2024.
2
Sex- and age-specific associations between abdominal fat and non-alcoholic fatty liver disease: a prospective cohort study.性别和年龄特异性与非酒精性脂肪肝的腹部脂肪的关系:一项前瞻性队列研究。
J Mol Cell Biol. 2024 Apr 10;15(11). doi: 10.1093/jmcb/mjad069.
3
Dual Role of Pregnane X Receptor in Nonalcoholic Fatty Liver Disease.
孕烷X受体在非酒精性脂肪性肝病中的双重作用
Curr Mol Pharmacol. 2023 Oct 13. doi: 10.2174/0118761429259143230927110556.
4
Analysis of factors affecting nonalcoholic fatty liver disease in Chinese steel workers and risk assessment studies.分析中国钢铁工人非酒精性脂肪肝的影响因素及风险评估研究。
Lipids Health Dis. 2023 Aug 9;22(1):123. doi: 10.1186/s12944-023-01886-0.
5
Analysis of risk factors related to nonalcoholic fatty liver disease: a retrospective study based on 31,718 adult Chinese individuals.非酒精性脂肪性肝病相关危险因素分析:一项基于31718名中国成年个体的回顾性研究。
Front Med (Lausanne). 2023 Jun 29;10:1168499. doi: 10.3389/fmed.2023.1168499. eCollection 2023.
6
Prevalence of nonalcoholic fatty liver disease and the related risk factors among healthy adults: A cross-sectional study in Chongqing, China.非酒精性脂肪性肝病在健康成年人中的流行情况及相关危险因素:一项在中国重庆的横断面研究。
Front Public Health. 2023 Mar 30;11:1127489. doi: 10.3389/fpubh.2023.1127489. eCollection 2023.
7
A TNFα/Miz1-positive feedback loop inhibits mitophagy in hepatocytes and propagates non-alcoholic steatohepatitis.TNFα/Miz1 正反馈环抑制肝细胞的线粒体自噬并促进非酒精性脂肪性肝炎。
J Hepatol. 2023 Aug;79(2):403-416. doi: 10.1016/j.jhep.2023.03.039. Epub 2023 Apr 9.
8
The Association of Sarcopenia and Visceral Obesity with Lean Nonalcoholic Fatty Liver Disease in Chinese Patients with Type 2 Diabetes Mellitus.中国 2 型糖尿病患者肌少症和内脏型肥胖与非酒精性脂肪肝瘦体组织含量的关系。
J Diabetes Res. 2022 Nov 4;2022:2229139. doi: 10.1155/2022/2229139. eCollection 2022.
9
Risk factors and prediction model for nonalcoholic fatty liver disease in northwest China.中国西北地区非酒精性脂肪性肝病的危险因素及预测模型。
Sci Rep. 2022 Aug 16;12(1):13877. doi: 10.1038/s41598-022-17511-6.
10
Liver injury in non-alcoholic fatty liver disease is associated with urea cycle enzyme dysregulation.非酒精性脂肪性肝病中的肝损伤与尿素循环酶失调有关。
Sci Rep. 2022 Mar 1;12(1):3418. doi: 10.1038/s41598-022-06614-9.